Finding the positives.....

I am trying to put together a list of potential positive announcements that may be forthcoming in the next few months

1. DEP Iri Ph2 Results
2. TGA guidance for VIRALEZE
3. License for any DEP product
4. VIVAGEL dist. agreements signed for already approved markets (what used to be Mundipharma markets)

For all the above points I am making the following assumptions

• DEP tech is the only thing that can get SPL SP back to the previous highs
• VIRALEZE is a dead duck and as such any approvals are meaningless as COVID is now over and the demand for this product is minimal.
• VIVAGEL has proven to also be a dead duck. Product in market for multiple years with minimal revenue

So in summary the fate of the company lies in the results of DEP Iri and then the subsequent commercialisation of the DEP tech. Company has on multiple occasions stated that they do not intend to progress these products beyond Ph2 Trials.

Cheryl would want to progress the commercialisation of DEP ASAP because the other sideshows (VIRALEZE/VIVAGEL) that JF was using to prop up the SP have now been shown for what they are..... Dead ducks!

If I have missed any other potential positives upcoming please feel free to post them and we can discuss, as always this in all my opinion only.